How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,722 results for

Mycosis Fungoides

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

61. Survival, disease progression and prognostic factors in elderly patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of 174 patients. (PubMed)

Survival, disease progression and prognostic factors in elderly patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of 174 patients. Advanced age at diagnosis is considered a poor prognostic factor in mycosis fungoides (MF) and Sézary syndrome (SS).To evaluate the outcomes and prognostic factors in patients diagnosed at an advanced age (≥65 years) with MF/SS.Survival, progression rates and various clinical and histopathological variables were studied in a group of 174

Full Text available with Trip Pro

2018 Journal of the European Academy of Dermatology and Venereology

62. Local radiation and phototherapy most cost-effective treatments for stage IA mycosis fungoides: a comparative decision-analysis model in the United States. (PubMed)

Local radiation and phototherapy most cost-effective treatments for stage IA mycosis fungoides: a comparative decision-analysis model in the United States. Treatments for early-stage mycosis fungoides (MF) include topical steroids, topical nitrogen mustard, topical bexarotene, narrowband ultraviolet B (NBUVB), psoralen plus ultraviolet A (PUVA), and local radiation. The relative cost-effectiveness of each treatment given the differences in treatment failure, disease progression, and therapy

2018 Journal of American Academy of Dermatology

63. Infectious events and associated risk factors in Mycosis Fungoides/Sézary Syndrome: a retrospective cohort study. (PubMed)

Infectious events and associated risk factors in Mycosis Fungoides/Sézary Syndrome: a retrospective cohort study. Infections are one of the major causes of death in patients with advanced-stage mycosis fungoides (MF) or Sézary syndrome (SS). However, few recent data are available on the characteristics and risk factors of these infectious events.To describe infectious events occurring in a cohort of patients with MF/SS, and to identify associated clinical and biological risk factors.A

2018 British Journal of Dermatology

64. Specific TCR gene rearrangements in mycosis fungoides: does advanced clinical stage show a preference? (PubMed)

Specific TCR gene rearrangements in mycosis fungoides: does advanced clinical stage show a preference? The relationship between the presence of specific T-cell receptor (TCR) gene rearrangements and clinical stage in mycosis fungoides (MF) has not been studied. We analysed a cohort of patients with a diagnosis of MF to determine the different types of specific TCR gene rearrangements present and their relationship to disease stage.A retrospective chart review was used to select patients

2018 Journal of Clinical Pathology

65. Folliculotropic Mycosis fungoides associated with GATA2 deficiency: a new skin manifestation. (PubMed)

Folliculotropic Mycosis fungoides associated with GATA2 deficiency: a new skin manifestation. 30101490 2018 12 03 1365-2133 179 6 2018 Dec The British journal of dermatology Br. J. Dermatol. Folliculotropic mycosis fungoides associated with GATA2 deficiency: a new skin manifestation. 1420-1421 10.1111/bjd.17081 Fertitta L L http://orcid.org/0000-0003-3528-9804 Department of Dermatology. Fontbrune F Sicre de FS Department of Haematology. Battistella M M Department of Pathology and. De Masson

2018 British Journal of Dermatology

66. PUVA and interferon-α2b combined therapy for patients with mycosis fungoides at different stages of the disease: a seven-year retrospective study in Russia. (PubMed)

PUVA and interferon-α2b combined therapy for patients with mycosis fungoides at different stages of the disease: a seven-year retrospective study in Russia. 30102807 2019 02 12 1468-3083 33 2 2019 Feb Journal of the European Academy of Dermatology and Venereology : JEADV J Eur Acad Dermatol Venereol PUVA and interferon α2b combined therapy for patients with mycosis fungoides at different stages of the disease: a seven-year retrospective study in Russia. e72-e74 10.1111/jdv.15212 Olisova O Y OY

2018 Journal of the European Academy of Dermatology and Venereology

67. Treatment of Early Folliculotropic Mycosis Fungoides with Special Focus on Psoralen plus Ultraviolet A. (PubMed)

Treatment of Early Folliculotropic Mycosis Fungoides with Special Focus on Psoralen plus Ultraviolet A. Data on the treatment of early folliculotropic mycosis fungoides, a recently defined clinicopathological subgroup of folliculotropic mycosis fungoides with an indolent course, is limited. Treatment outcomes were studied in a retrospective cohort of 47 adults with early folliculotropic mycosis fungoides, with a focus on psoralen plus ultraviolet A (PUVA) monotherapy, including dosimetric data (...) , and the findings were compared with data for PUVA in 18 adults with early-classic mycosis fungoides. PUVA was given to 27 patients with early folliculotropic mycosis fungoides: 70% achieved complete response and 26% partial response. Significantly more treatments were needed to achieve complete response in stage IB compared with stage IA. There was no significant difference in the complete response rate from classic plaque-stage disease, although the early folliculotropic mycosis fungoides group required more

Full Text available with Trip Pro

2018 Acta Dermato-Venereologica

68. Folliculotropic Mycosis Fungoides in 20 Korean Cases: Clinical and Histopathologic Features and Response to Ultraviolet A-1 and/or Photodynamic Therapy (PubMed)

Folliculotropic Mycosis Fungoides in 20 Korean Cases: Clinical and Histopathologic Features and Response to Ultraviolet A-1 and/or Photodynamic Therapy Folliculotropic mycosis fungoides (FMF) is a variant of mycosis fungoides (MF) that is characterized clinically by variable types of skin eruptions, including plaques, acneiform lesions, and alopecic patches. Histopathologically, FMF is characterized by folliculotropic infiltrates.This study was conducted to scrutinize the clinical

Full Text available with Trip Pro

2018 Annals of dermatology

69. Exacerbation of mycosis fungoides leading to the diagnosis of chronic myelomonocytic leukemia (PubMed)

Exacerbation of mycosis fungoides leading to the diagnosis of chronic myelomonocytic leukemia 29687069 2019 02 26 2352-5126 4 3 2018 Apr JAAD case reports JAAD Case Rep Exacerbation of mycosis fungoides leading to the diagnosis of chronic myelomonocytic leukemia. 270-273 10.1016/j.jdcr.2017.09.023 Moritz Rose K C RKC Department of Dermatology and Venereology, University Hospital Halle (Saale), Halle (Saale), Germany. Metze Dieter D Department of Dermatology, University Hospital Muenster (...) of Dermatology, University Hospital Muenster, Muenster, Germany. eng Case Reports 2018 03 06 United States JAAD Case Rep 101665210 2352-5126 AML, acute myeloid leukemia CMML, chronic myelomonocytic leukemia MF, mycosis fungoides MPO, myeloperoxidase PUVA, psoralen ultraviolet A bexarotene chronic myelomonocytic leukemia cutaneous lymphoma mycosis fungoides 2018 4 25 6 0 2018 4 25 6 0 2018 4 25 6 1 epublish 29687069 10.1016/j.jdcr.2017.09.023 S2352-5126(17)30232-1 PMC5909678 J Clin Oncol. 2002 May 15;20(10

Full Text available with Trip Pro

2018 JAAD Case Reports

70. Transformation of Mycosis Fungoides/Sezary Syndrome: Clinical Characteristics and Prognosis (PubMed)

Transformation of Mycosis Fungoides/Sezary Syndrome: Clinical Characteristics and Prognosis Transformed mycosis fungoides (T-MF) is a rare variant of MF with an aggressive course. In this study, we aimed to describe characteristics of MF/Sezary syndrome (SS) patients with transformation.Patients diagnosed with T-MF among MF/SS patients between 2000 and 2014 in a tertiary single center were evaluated retrospectively. Demographic data, clinical data, laboratory data, immunophenotype features

Full Text available with Trip Pro

2018 Turkish Journal of Hematology

71. Tumoral Melanosis Arising on a Mycosis Fungoides Plaque (PubMed)

Tumoral Melanosis Arising on a Mycosis Fungoides Plaque 30203781 2019 01 30 2146-3131 35 6 2018 11 15 Balkan medical journal Balkan Med J Tumoral Melanosis Arising on a Mycosis Fungoides Plaque 447-448 10.4274/balkanmedj.2018.0936 Demirdağ Hatice Gamze HG 0000-0001-9484-2054 Department of Dermatology, University of Health Sciences, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Turkey Akay Bengü Nisa BN 0000-0002-4896-1666 Department of Dermatology, Ankara

Full Text available with Trip Pro

2018 Balkan medical journal

72. Early dermoscopic sign of folliculotropism in patients with mycosis fungoides (PubMed)

Early dermoscopic sign of folliculotropism in patients with mycosis fungoides 30479867 2018 12 07 2160-9381 8 4 2018 Oct Dermatology practical & conceptual Dermatol Pract Concept Early dermoscopic sign of folliculotropism in patients with mycosis fungoides. 328-329 10.5826/dpc.0804a17 Toncic Ruzica Jurakic RJ Department of Dermatology and Venereology, University Hospital Centre Zagreb, University of Zagreb School of Medicine, Zagreb, Croatia. Drvar Daniela Ledic DL Department of Dermatology (...) , Croatia. Caccavale Stefano S Dermatology Unit, Department of Mental and Physical Health and Preventive Medicine, University of Campania Luigi Vanvitelli, Naples, Italy. Argenziano Giuseppe G Dermatology Unit, University of Campania, Nuovo Policlinico, Naples, Italy. eng Journal Article 2018 10 31 United States Dermatol Pract Concept 101585990 2160-9381 dermoscopy folliculotropic mycosis fungoides folliculotropism mycosis fungoides primary cutaneous lymphoma Competing interests: The authors have

Full Text available with Trip Pro

2018 Dermatology practical & conceptual

73. Dramatic response to brentuximab vedotin in a refractory non-transformed CD30-negative mycosis fungoides allowing allogeneic stem cells transplantation and long-term complete remission. (PubMed)

Dramatic response to brentuximab vedotin in a refractory non-transformed CD30-negative mycosis fungoides allowing allogeneic stem cells transplantation and long-term complete remission. The erythrodermic ulcerated form of mycosis fungoides (MF) is exceptional, and treatment of refractory cases is challenging. Brentuximab vedotin (BV) is a monoclonal antibody combined with monomethyl auristatin E, recently approved for the treatment of refractory CD30+ cutaneous T-cell lymphoma. We report a case

2018 British Journal of Dermatology

74. Treatment of mycosis fungoides and Sezary syndrome with romidepsin: a series of 32 cases of the French Study Group for Cutaneous Lymphoma. (PubMed)

Treatment of mycosis fungoides and Sezary syndrome with romidepsin: a series of 32 cases of the French Study Group for Cutaneous Lymphoma. 30298903 2019 02 04 1365-2133 180 2 2019 Feb The British journal of dermatology Br. J. Dermatol. Treatment of mycosis fungoides and Sézary syndrome with romidepsin: a series of 32 cases from the French Study Group for Cutaneous Lymphoma. 423-424 10.1111/bjd.17269 Deschamps O O http://orcid.org/0000-0003-0270-5920 Department of Dermatology, Hôpital Saint

2018 British Journal of Dermatology

75. Unilesional mycosis fungoides is associated with increased expression of microRNA-17~92, and Th1 skewing. (PubMed)

Unilesional mycosis fungoides is associated with increased expression of microRNA-17~92, and Th1 skewing. The molecular basis of unilesional mycosis fungoides (MF), characterized by a solitary lesion that is clinicopathologically indistinguishable from multifocal patch or plaque MF (early MF), is unknown.To investigate the microRNA profile in unilesional MF distinguishing it from early MF.Biopsy samples of unilesional MF and early MF were evaluated with the Affymetrix microRNA array

2018 British Journal of Dermatology

76. The PROCLIPI international registry of early stage Mycosis Fungoides identifies substantial diagnostic delay in most patients. (PubMed)

The PROCLIPI international registry of early stage Mycosis Fungoides identifies substantial diagnostic delay in most patients. Survival in mycosis fungoides (MF) is varied and may be poor. The PROCLIPI (PROspective Cutaneous Lymphoma International Prognostic Index) study is a web-based data collection system for early-stage MF with legal data-sharing agreements permitting international collaboration in a rare cancer with complex pathology. Clinicopathological data must be 100% complete

2018 British Journal of Dermatology

77. Spiky follicular Mycosis Fungoides : A trichoscopic feature. (PubMed)

Spiky follicular Mycosis Fungoides : A trichoscopic feature. We have read with great interest a case report published by Slawinka et al describing trichoscopic spectrum of folliculotropic mycosis fungoides (FMF) [1]. Different trichoscopic aspects were reported by authors as the presence of milky white globules, yellow dots, short hair with split or triangle-shaped end, broken hair and pigtail appearance hair. This article is protected by copyright. All rights reserved.This article is protected

2018 Journal of the European Academy of Dermatology and Venereology

78. Healthcare resource utilization, costs of care, and treatment of mycosis fungoides cutaneous T-cell lymphoma patterns in a large managed care population: a retrospective US claims-based analysis. (PubMed)

Healthcare resource utilization, costs of care, and treatment of mycosis fungoides cutaneous T-cell lymphoma patterns in a large managed care population: a retrospective US claims-based analysis. To evaluate health care utilization, treatment patterns and costs among patients with mycosis fungoides-cutaneous T-cell lymphoma (MF-CTCL).This retrospective cohort study queried the HealthCore Integrated Research Database to identify patients ≥18 years with ≥2 diagnoses of MF-CTCL (ICD-9-CM code

Full Text available with Trip Pro

2018 Journal of Dermatological Treatment

79. Mycosis fungoides variants-clinicopathologic features, differential diagnosis, and treatment. (PubMed)

Mycosis fungoides variants-clinicopathologic features, differential diagnosis, and treatment. Mycosis fungoides (MF) is the most common type of cutaneous T-cell lymphoma, which typically presents with erythematous patches and plaques, histopathologically characterized by superficial infiltrates of small to mediumsized atypical epidermotropic T cells. Apart from this classic type of MF, many clinical and/or histopathologic variants have been described. Correct diagnosis of these MF variants

2018 Seminars in Cutaneous Medicine and Surgery

80. Mycosis fungoides-clinical and histopathologic features, differential diagnosis, and treatment. (PubMed)

Mycosis fungoides-clinical and histopathologic features, differential diagnosis, and treatment. Mycosis fungoides (MF) is the most common type of cutaneous lymphoma. The term MF should be used only for the classical presentation of the disease characterized by the evolution of patches, plaques, and tumors or for variants showing a similar clinical course. MF is divided into 3 clinical phases: patch, plaque, and tumor stage, and the clinical course is usually protracted over years or decades

2018 Seminars in Cutaneous Medicine and Surgery

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>